EUVIMEDEUVIMED entdecken
Crossref

Reactive Oxygen Species Responsive Multifunctional Fusion Extracellular Nanovesicles: Prospective Treatments for Acute Heart Transplant Rejection

Xingyu Lu iD, Zhanxue Xu iD, Fan Shu, Yidan Wang, Yuhang Han, Xinrui Yang, Peilin Shi, Chuanqiang Fan, Linglu Wang, Fei Yu, Qipeng Sun, Fang Cheng und 1 weitere

Advanced Materials · 2024-08 · 36 (35)

DOI: 10.1002/adma.202406758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 01.07.2024. Verfasst von Xingyu Lu und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: Heart Transplantation, Reactive Oxygen Species, Graft Rejection, Sirolimus. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, China Postdoctoral Foundation Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart transplantation offers life‐saving treatment for patients with end‐stage heart failure; however, ischemia‐reperfusion injury (IRI) and subsequent immune responses remain significant challenges. Current therapies primarily target adaptive immunity, with limited options available for addressing IRI and innate immune activation. Although plant‐derived vesicle‐like nanoparticles show promise in managing diseases, their application in organ transplantation complications is unexplored. Here, this work develops a novel reactive oxygen species (ROS)‐responsive multifunctional fusion extracellular nanovesicles carrying rapamycin (FNVs@RAPA) to address early IRI and Ly6C + Ly6G − inflammatory macrophage‐mediated rejection in heart transplantation. The FNVs comprise Exocarpium Citri grandis ‐derived extracellular nanovesicles with anti‐inflammatory and antioxidant properties, and mesenchymal stem cell membrane‐derived nanovesicles expressing calreticulin with macrophage‐targeting ability. A novel ROS‐responsive bio‐orthogonal chemistry approach facilitates the active targeting delivery of FNVs@RAPA to the heart graft site, effectively alleviating IRI and promoting the polarization of Ly6C + Ly6G − inflammatory macrophages toward an anti‐inflammatory phenotype. Hence, FNVs@RAPA represents a promising therapeutic approach for mitigating early transplantation complications and immune rejection. The fusion‐targeted delivery strategy offers superior heart graft site enrichment and macrophage‐specific targeting, promising improved transplant outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationReactive Oxygen SpeciesGraft RejectionSirolimusMacrophagesAnimalsMiceExtracellular VesiclesNanoparticlesCalreticulinReperfusion InjuryMesenchymal Stem Cells

Stichwörter der Autor:innen

bio‐orthogonal chemistryfusion extracellular nanovesiclesheart transplantationischemia‐reperfusion injury

Substanzen

Reactive Oxygen SpeciesSirolimusCalreticulin

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China.
  • Department of Pharmacy, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, China.
  • Department of Kidney Transplantation, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.

ORCID-Profile: Xingyu Lu, Zhanxue Xu, Hongbo Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • China Postdoctoral Foundation Science Foundation
  • Open project of State Key Laboratory of Respiratory Diseases
  • High-level talent introduction supporting scientific research funds of Guangdong Provincial People's Hospital
  • Shenzhen Science and Technology Innovation Program
  • National Key R&D Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Lu, X., Xu, Z., Shu, F., Wang, Y., Han, Y., Yang, X., Shi, P., Fan, C., Wang, L., Yu, F., Sun, Q., Cheng, F., & Chen, H. (2024). Reactive Oxygen Species Responsive Multifunctional Fusion Extracellular Nanovesicles: Prospective Treatments for Acute Heart Transplant Rejection. Advanced Materials, 36(35). https://doi.org/10.1002/adma.202406758

Vancouver

Lu X, Xu Z, Shu F, Wang Y, Han Y, Yang X, et al. Reactive Oxygen Species Responsive Multifunctional Fusion Extracellular Nanovesicles: Prospective Treatments for Acute Heart Transplant Rejection. Advanced Materials. 2024;36(35). doi:10.1002/adma.202406758

BibTeX
@article{Lu2024,
  author = {Lu, Xingyu and Xu, Zhanxue and Shu, Fan and Wang, Yidan and Han, Yuhang and Yang, Xinrui and Shi, Peilin and Fan, Chuanqiang and Wang, Linglu and Yu, Fei and Sun, Qipeng and Cheng, Fang and Chen, Hongbo},
  title = {Reactive Oxygen Species Responsive Multifunctional Fusion Extracellular Nanovesicles: Prospective Treatments for Acute Heart Transplant Rejection},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {35},
  doi = {10.1002/adma.202406758}
}
Kostenlos starten →